Articles tagged "Graft failure"

2020 American Transplant Congress
Comparative Analysis of Patient Outcomes between Urology-Led versus General Surgery-Led Kidney Transplant Centers
A. Mishra¹, A. Cohen¹, N. Koizumi², A. Ortiz³, K. Pai¹, B. Bullock¹, S. Sureddi¹, J. Ortiz¹
¹The University of Toledo College of Medicine and Life Sciences, Toledo, OH, ²George Mason University, Arlington, VA, ³Albany Medical College, Albany, NY
*Purpose: To assess renal patient outcomes between kidney transplant centers across the United States based on whether their surgical leader was initially trained via the…
2020 American Transplant Congress
Calcium Oxalate Deposition in Kidney Allografts: Clinical Chracteristics and Outcome
S. Sritharan¹, J. Kamal², S. A. Husain¹, I. Batal¹, J. Chang¹
¹Columbia University Irving Medical Center, New York, NY, ²University of Virginia, Charlottesville, VA
*Purpose: To better understand its clinical significance and prognostic value, we investigated the clinical characteristics and outcomes of patients with calcium oxalate deposition in kidney…
2020 American Transplant Congress
Allograft Loss and Patient Death among Kidney Transplant Recipients; Is Therapy Non-Adherence the Underlying Perpetrator?
K. Kalra, R. Munjal, A. Cherukuri, R. Mehta, C. Puttarajappa, D. Jorgensen, P. Sood, C. Wu, N. Shah, S. Hariharan
Nephrology, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: To ascertain causes of allograft dysfunction, loss and death in a cohort of kidney transplant patients*Methods: In this Retrospective cohort study, 943 patients who…
2020 American Transplant Congress
Ranking Eplet Mismatches as Predictors of Graft Failure
W. Zhang¹, H. Mohammadhassanzadeh¹, K. Oualkacha², H. Gebel³, W. Klement⁴, R. Sapir-Pichhadze¹
¹McGill University, Montreal, QC, Canada, ²UQAM, Montreal, QC, Canada, ³Emory University Hospital, Atlanta, GA, ⁴Canadian Blood Services, Ottawa, ON, Canada
*Purpose: Donor:recipient matching at the level of sequence defined HLA targets (eplets) is being promoted as a biologically sound strategy to prevent graft failure. Because…
2020 American Transplant Congress
Comparison of 4 vs 14 Days Early Steroid Withdrawal in Kidney Transplant Recipients
O. Adebiyi, J. Chen, B. Brady, S. Mietz, T. Taber, D. Mishler, M. Yaqub, W. Goggins, A. Sharfuddin
Indiana University, Indianapolis, IN
*Purpose: The optimal duration, as well as the dose of the initial steroid use, is not known as it varies widely among institutions that have…
2020 American Transplant Congress
Recurrent Focal Segmental Glomerulosclerosis and the Possibility of Re-Transplantation
E. L. Wood¹, J. Burrows¹, E. Lum, MD², J. Veale, MD¹
¹Urology, UCLA, Los Angeles, CA, ²Nephrology, UCLA, Los Angeles, CA
*Purpose: Up to 30% of patients with focal segmental glomerulosclerosis (FSGS) experience recurrent disease after renal transplant, with high rates of progression to allograft failure…
2020 American Transplant Congress
Graft and Patient Survival after A2-Incompatible Living Donor Kidney Transplantation
S. Getsin, P. Chiang, S. Yu, K. Jackson, D. Segev, A. Massie
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: ABO type B and O recipients have increased difficulty identifying a compatible donor for living-donor kidney transplantation (LDKT), and are harder to match in…
2020 American Transplant Congress
Outcomes of Acute Allograft Rejection Treatment with R Anti-Thymocyte Globulin (r-ATG) One Year Post Kidney Transplant
M. Yaqub, A. Riaz, D. Mishler, O. Adebiyi, T. Taber, A. Sharfuddin
Indiana University School of Medicine, Indianapolis, IN
*Purpose: Acute allograft rejection is considered one of the major causes of renal allograft dysfunction. Despite maximal anti-rejection therapy grafts may not regain baseline function.…
2020 American Transplant Congress
Causes of Kidney Allograft Loss (GL) in the Current Era of Donor-Specific Alloantibody (DSA) Testing
M. Merzkani¹, X. Benavides¹, M. D'Costa¹, B. Smith¹, W. Park¹, A. Rule¹, H. Chakkera², K. Reddy², M. Alexander¹, H. Amer¹, M. El Ters¹, C. Schinstock¹, R. Heilman², A. Bentall¹, M. Stegall¹
¹Mayo Clinic, Rochester, MN, ²Mayo Clinic, Scottsdale, AZ
*Purpose: The goal of this study was to examine the causes and risk factors (RF) for renal GL in the era since the widespread adoption…
2020 American Transplant Congress
Adult Primary Liver Transplant Recipient Outcomes by Immunosuppression Induction Received
T. Shaker¹, G. Larrieux¹, S. Jackson², S. Riad³, T. Pruett¹, T. Leventhal⁴
¹Surgery, Division of Transplantation, University of Minnesota, Minneapolis, MN, ²M Health Fairview, Minneapolis, MN, ³Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, ⁴Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN
*Purpose: It has long been recognized that the highest risk of rejection of an organ is in the first few months post transplantation. To prevent…